SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Natco Pharma’s arm acquires 49% stake in PT NATCO Lotus Farma

30 Jan 2026 Evaluate

Natco Pharma’s wholly-owned subsidiary (WOS) -- NATCO Pharma Asia has acquired 49% of shareholding in PT NATCO Lotus Farma from PT Lotus Farma Indonesia. The company already owns 51% of PT NATCO Lotus Farma. Post this acquisition, the company along with its WOS wholly-owns 100% of PT NATCO Lotus Farma.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.


Natco Pharma Share Price

918.00 -0.90 (-0.10%)
05-Jun-2026 09:23 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1792.60
Dr. Reddys Lab 1279.20
Cipla 1395.00
Zydus Lifesciences 1089.40
Lupin 2300.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×